Manuscript Submission Guidelines
manuscript submission process is organized through the Rapid Review website. Before you submit your manuscript, you'll need to log in to your Rapid Review account
. If you don't have a Rapid Review account click here
to create one.
You can log in to your Rapid Review account by clicking here
is the official publication of the Associated Professional Sleep Societies, LLC (APSS), a joint venture of the American Academy of Sleep Medicine (AASM) and the Sleep Research Society (SRS).
It is a monthly, peer-reviewed scientific and medical journal that is published online. It features a wide spectrum of sleep-related research, and the primary audiences are clinicians and research professionals specializing in sleep-related disorders.
AASM and SRS members and journal subscribers have access to all new and archived articles. All articles are available to the public as open access six months after publication.
2014 Impact Factor: 4.591
5-year Impact Factor: 5.753
Google Scholar: h-5 index of 63 and an h-5 median of 87 – 1st in the category of sleep
Circulation: Approximately 13,000
Visitors: Approximately 32,000 monthly, including 115,000 page views
Increase exposure to your research by publishing in SLEEP:
- Accepted papers are immediately available on the SLEEP website for viewing by all AASM and SRS members and subscribers
- Copyedited versions of accepted abstracts are available on PubMed as Ahead of Print.
- All articles are available via open access to the public six months after publication (with only a $50 manuscript submission fee).
- Noteworthy manuscripts are promoted to various national and local press via the journal’s public relations staff.
MANUSCRIPT SUBMISSION INSTRUCTIONS
Articles cannot be concurrently submitted or published by any other publication, print or electronic, except in abstract format. The APSS is not responsible in the event that any manuscript, or any part thereof, is lost.
All materials are submitted and edited electronically using Rapid Review. To submit an original manuscript, short note, editorial, rapid publication, review article, book review, or letter to the editor, please go to https://www.rapidreview.com/AASM/CALogon.jsp. Complete instructions for the electronic submission process can be found on this site.
To help offset publishing costs, there is a nominal, nonrefundable submission fee of $50 for all original scientific manuscripts submitted for publication in SLEEP. No fee will be required for other types of papers such as book reviews, editorials and letters to the editor. This fee will be collected during the manuscript submission process and is nonrefundable.
SCOPE/CATEGORIES OF MANUSCRIPTS
SLEEP publishes original findings and analysis related to sleep disorders, medical dysfunctions during sleep, clinical investigations, therapeutic trials, physiologic events, anatomic structures and molecular components underlying normal and abnormal sleep, psychological and psychophysiologic research, and the pharmacology of sleep.
Manuscripts must not be concurrently submitted to any other publication, print or electronic. Accepted manuscripts become the permanent property of the APSS and may not be published elsewhere without written permission from the APSS. All accepted manuscripts and supporting documents are subject to manuscript copyediting for conciseness, clarity, grammar, spelling, and SLEEP journal style.
The following types of manuscripts are accepted:
Original Manuscripts should include ground-breaking research in the field of sleep, novel findings and analysis related to sleep disorders, medical dysfunctions during sleep, clinical investigations, therapeutic trials, physiologic events, anatomic structures and molecular components underlying normal and abnormal sleep, psychological and psychophysiologic research, and the pharmacology of sleep.
Papers of sufficient scientific importance and interest to the clinical and research community that warrant a rapid publication process may be submitted under this category. The standard review and processing procedures used by SLEEP may be substantially accelerated such that a paper may move from original submission to final acceptance in about three weeks and to publication in about eight weeks. This process is now available to any study of major scientific importance. Papers that ultimately meet the standard for publication in SLEEP may not be appropriate for rapid publication. Papers that, in the judgment of the Editor-in-Chief or in the judgment of the appropriate Associate Editor, do not meet these criteria will be returned to the author without review or reviewed as an original manuscript. Rapid publication is not a mechanism to have all papers reviewed more quickly, rather it is reserved for scientifically, highly meritorious work; authors are expected to respect these guidelines.
Review articles on important topics can be submitted to SLEEP for consideration. Review articles, including meta-analyses, are critical evaluations of material that has already been published. An author of a review article should consider the progress of current research toward clarifying a problem. A review paper should summarize previous investigations in order to inform the reader of the state of current research; identify relations, contradictions, gaps, and inconsistencies in the literature; and suggests the next step or steps in solving the problem. The review section may also include summaries of symposia presentations at national or international meetings. Editors will initially review these submissions for merit and request peer reviews if deemed appropriate. Additions and changes may be requested of the author to better communicate the state of the art presented in the review.
Short Notes, Editorials, Letters to the Editor, or Book Reviews
Short notes may be a maximum of six double-spaced, typewritten pages. One figure or one table may be added. Editorials and letters to the editor should be no more than one or two double-spaced pages. References should be limited to no more than ten. Books to be considered for review may be sent to SLEEP Book Editor, 2510 North Frontage Road, Darien, IL 60561. Book reviews are solicited by the Editor-in-Chief.
REQUIRED FORMS FOR SUBMISSION
Please note that no submission will be considered for review past the initial submission without receipt of all required submission forms.
These form are interactive PDFs. Save a copy to your computer, and complete it by typing directly into the fields. (Please follow the instructions on the form.) The file(s) of the completed form(s) must be uploaded as a “Forms” option during the Upload Files section as part of your manuscript submission. In extenuating circumstances, the form(s) may be emailed to firstname.lastname@example.org. However, we strongly encourage all forms be uploaded as directed above.
Copyright Assignment and CME Educational Objective Form (Transfer of Author Copyright)
Published manuscripts become the permanent property of the APSS and may not be published elsewhere without written permission from the APSS. All authors must sign the Copyright Assignment and CME Educational Objective Form. The form must be submitted with every manuscript submission.
The form requires authors to write a broad, one-sentence learning object to accompany their manuscript. While completing the CME educational objective portion of the form, authors should keep in mind the overall learning objectives of the journal SLEEP. After reading each issue, readers should be able to: 1) appraise sleep research in basic science and clinical investigation; 2) interpret new information and updates on clinical diagnosis/treatment and apply those strategies to their practice; 3) analyze articles for the use of sound scientific and medical procedures; and 4) recognize the inter-relatedness/dependence of sleep medicine with primary disciplines.
Conflict of Interest Disclosure and Attestation of Authorship Form
All authors must disclose all potential conflicts of interest and verify authorship by submitting the Conflict of Interest Disclosure and Attestation of Authorship Form. This form is required of all authors and must be submitted during the initial submission of a manuscript.
Substantive changes to the disclosure must be reported as they occur. Papers that report on intervention studies on biologicals or technologies must indicate separately in the disclosure what company made and/or markets the product tested. Conflicts of interest will be reviewed by the Editor-In-Chief and the SLEEP staff. This information will be listed within the article, but dollar amounts will not be included.
These same conflicts or lack thereof for each author must be included on the title page of every manuscript submission. No submission will be considered for review without complete disclosure(s) included on the title page.
Each author should have participated sufficiently in the work and analysis of data, as well as the writing of the manuscript, for his or her name to be listed as a co-author and is required to attest to this responsibility on the form. While not a requirement, it is strongly suggested that authors be limited to 15 or less for any manuscript submission.
ESSENTIAL ELEMENTS OF MANUSCRIPT SUBMISSION
Clinical Trial Registration
now requires that all clinical trials, regardless of when they were completed, and all partial and secondary analyses of original clinical trials must be registered before submission of a manuscript based on the trial. Trials must have been registered at or before the onset of patient enrollment for any clinical trial that began patient enrollment on or after February 1, 2007. The trial name, URL, and registration number should be included at the end of the manuscript abstract.
The following trial registries are acceptable:
Ethics of Investigation
Authors should specify within the manuscript whether ethical standards were used in their research. If results of an experimental investigation in human or animal subjects are reported, the manuscript should include the notation that the institutional review board on human or animal research approved the study and that appropriate informed consent was obtained from human subjects. If approval by an institutional review board is not possible, then information must be included indicating that clinical experiments conform to the principals outline by the Declaration of Helsinki.
Privacy and Informed Consent
Authors must omit from their manuscripts and figures any identifying details regarding patients and study participants, including patients’ names, initials, Social Security numbers, or hospital numbers. If there is a possibility that a patient may be identified in text, figures, photos or video, authors must obtain written informed consent for use for in publication of print, online, and licensed uses of SLEEP, from the patient or parent or guardian and provide copies of the consent forms to SLEEP. In such cases where the patient may be identified, authors must indicate that they have obtained informed consent in their manuscript. In addition, all authors are responsible for ensuring that their manuscript and figures comply with the Health Insurance Portability and Accountability Act (HIPAA) (www.hhs.gov/ocr/hipaa).
All papers must be double spaced, have one-inch margins (top, bottom, and sides), and include page numbers.
Manuscript should be structured using the following components:
The title page must include the following:
- Title and subtitle
- Full first and last names, highest academic degrees, and institutional affiliations for all authors
- The institution at which the work was performed
- Disclosure of the presence OR absence of financial support
- Disclosure of any off-label or investigational use
- Disclosure of the presence OR absence of any conflicts of interest for each author to match what is indicated on their individual Conflict of Interest form
- Clinical trial name, URL, and registration number (if no clinical trial is indicated, please include a statement to this effect)
- Corresponding author’s full address, phone and fax numbers and e-mail address
- The total number of figures
- The total number of tables
No submission will be considered for review without all of the above information.
Each original manuscript, rapid publication, and short note must be preceded by a structured abstract. The abstract is limited to 250 words. The components of this format are (start each on a new line): Study Objectives, Methods, Results, Conclusions and Keywords.
Conclusions should not simply restate results and should include as few abbreviations as possible. Abstracts are not required for letters to the editor, editorials and book reviews. Please provide no fewer than three but no more than ten keywords that reflect the content of your manuscript. For guidance consult the Medical Subject Headings - Annotated Alphabetic List, published each year by the National Library of Medicine.
Statement of Significance
The statement of significance will appear on the first page of the manuscript just below the abstract.
The statement of significance should:
- Be no more than 120 words maximum
- NOT be repetitious with the abstract or the “In summary…” paragraph that is often placed at the end of the discussion
- NOT contain references and should avoid numbers, description of methods and acronyms unless necessary
- Provide a clear statement of the importance and novelty of the research, using language that can be understood by scientists or clinicians without special knowledge of the field
- Include a statement about critical remaining knowledge gaps and/or future directions of the work
- For basic science papers, include a reasonable statement about human disease relevance and/or translational implications
State the object of research with reference to previous work.
Describe methods in sufficient detail so that the work can be duplicated, or cite previous descriptions if they are readily available.
Describe results clearly, concisely, and in logical order. When possible give the range, standard deviation, or mean error, and significance of differences between numerical values.
Interpret the results and relate them to previous work in the field. Include a paragraph near the end of the discussion that briefly lists the limitations of the study.
The minimum compatible with the requirements of courtesy should be provided.
Figures and Tables
View SLEEP guidelines for figures and tables.
View SLEEP guidelines for supplemental materials.
SLEEP complies with the reference style given in "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (see International Committee of Medical Journal Editors (ICMJE) online). Each reference should be cited in the text, tables, or figures in consecutive numerical order by means of superscripted Arabic numerals outside periods and commas and inside colons and semicolons. When three or more references are cited at one place in the manuscript, a hyphen should be used to join the first and last numbers of a series; commas should be used without spaces to separate other parts of a multiple-reference citation. There is no limit on the number of references for original articles. The reference section should be included starting on a separate page at the end of the text, following the style of the sample formats given below. It is highly recommended that a standard bibliography program such as EndNote or Reference Manager be used. For EndNote users, the formatting style for SLEEP should be used. For abbreviations of journal names, refer to “List of Journals Indexed in Index Medicus.” Provide all authors' names when fewer than seven; when seven or more, list the first three and add et al. Provide article titles and inclusive pages. Note that SLEEP does not include the issue number in its reference style. Accuracy of reference data is the responsibility of the author. We cannot guarantee that citation/reference software will match all SLEEP author guidelines. Failure to initially comply with SLEEP’s style requirements may result in manuscripts returned to authors for correction and may potentially delay publication.
Sample citations within the body of a paper
According to our previous work,1,3-8,19
The patients were studied as follows3,4:
1. Kapur VK, Baldwin CM, Resnick HE, Gottlieb DJ, Nieto FJ. Sleepiness in patients with moderate to severe sleep-disordered breathing. Sleep 2005;28:472-7.
2. Quan SF, Howard BV, Iber C, et al. The Sleep Heart Health Study: design, rationale, and methods. Sleep 1997;20:1077-85.
3. Guilleminault C, Lugaresi E, eds. Sleep/wake disorders: natural history, epidemiology, and long-term evolution. New York: Raven Press, 1983.
Chapter of a book:
4. Coleman RM, Bliwise DL, Sajben N, et al. Epidemiology of periodic movements during sleep. In: Guilleminault C, Lugaresi E, eds. Sleep/wake disorders: natural history, epidemiology, and long-term evolution. New York: Raven Press, 1983:217-30.
5. “Journals,” American Academy of Sleep Medicine, accessed August 26, 2015, http://www.aasmnet.org/journals.aspx.
DETAILS OF STYLE
Sleep Medicine Terminology
Follow the terminology usage recommendations in the AASM Style Guide for Sleep Medicine Terminology
Use generic names in referring to drugs; trade names may be given in parentheses after the first mention, but the generic name should be used thereafter.
Follow the list of abbreviations given in "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (see section on References). For additional abbreviations, consult the Council of Biology Editors Style Manual (available from the Council of Biology Editors, Inc., 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Please note that journal style for the abbreviation of standard deviation is SD. Please do not use SD as an abbreviation for sleep deprivation.
Please provide on a separate page all abbreviations used with their full definition. Each should be expanded at first mention in the text and listed parenthetically after expansion.
Editors first determine if a submitted manuscript is suitable for review and publication. Manuscripts selected are then sent for peer-review to reviewers who are selected based on their expertise related to the particular manuscript. After reviews are in, a recommendation of accept, reject or revise (for further consideration) is made by the Associate Editor to the Editor-in-Chief, who makes the final decision.
Manuscripts are reviewed with due respect for the author's confidentiality. At the same time, reviewers also have rights to confidentiality, which are respected by the editors. The editors ensure both the authors and the reviewers that the manuscripts sent for review are privileged communications and are the private property of the author.
When submitting a manuscript for consideration for publication, authors may suggest the names of potential reviewers to invite and/or exclude.
If a manuscript is returned to the author(s) for revisions, all resubmissions must follow the Instructions for Submitting a Manuscript and include the following:
- Both a clean copy and a redline copy of the revised submission. NOTE: If the redline copy was created using “track changes” mode in Word, please create a PDF file of the redline version and upload the PDF file in Rapid Review. If you are not able to create a PDF file of your redline version, please use alternative font colors or highlighting tools in Word to show the redlined changes – not “track changes” mode.
- You must also upload a letter (Corresponding Author’s Rebuttal) responding to each of the points made by the reviewers.
The deadline for submission of a revised manuscript needing major revisions is two months from the date of the notice. For Minor revisions, the deadline for resubmission is one month. There is no guarantee that a revised manuscript will be accepted for publication.
EXPEDITED REVIEW PROCESS
At the option of the authors, manuscripts previously peer-reviewed by SLEEP, but not accepted for publication may be considered for expedited review for Journal of Clinical Sleep Medicine (JCSM). An expedited review will consist of an analysis by the Editor-in-Chief of JCSM of the previous critiques returned by SLEEP as well as an examination of the submitted manuscript. Using these documents, an initial decision of accept, reject or revision will be made without additional outside reviews. To obtain an expedited review, the corresponding author MUST request this in the cover letter to JCSM. The authors must include the critiques returned from SLEEP, a detailed response to each of these critiques, and both a track changes and a clean version of the paper. The Editor-in-Chief will decide whether to conduct an expedited review or to proceed with the standard review process. If a decision is made to conduct a standard review, the author will be so informed and given the option to withdraw the manuscript without prejudice.
The editorial office carefully monitors papers submitted to SLEEP for plagiarism. We define plagiarism to include: literal copying - reproducing a work word for word, in whole or in part, without permission and acknowledgment of the original source; paraphrasing - reproducing someone else's ideas while not copying word for word, without permission and acknowledgment of the original source; substantial copying - copying images, or data from other sources; text-recycling - reusing text from your own previous publications.
Any text contained in a manuscript that is directly copied from another source must be placed within quotation marks and the original source must be properly cited. If a paper captures the essence of a previously published work, that work should be cited. If any paraphrasing is included, the source must be properly referenced and the meaning intended by the source must not be changed. All works that may have inspired a study’s design or manuscript structure must be properly cited.
If plagiarism is detected during any part of the peer review process, the manuscript may be rejected. For published papers where plagiarism is detected, we reserve the right to issue a correction or retract the paper, whichever is deemed appropriate. We reserve the right to inform authors' institutions about plagiarism detected either before or after publication.
All accepted manuscripts are subject to manuscript editing for conciseness, clarity, grammar, spelling and SLEEP style. After acceptance all manuscripts will be copyedited. The copyedited version will be sent to the corresponding author for review and approval and returned to the Managing Editor. Once the manuscript is scheduled for publication, the corresponding author will be notified as to the assignment of the manuscript to an issue and page proofs will be sent to the corresponding author. These proofs will be emailed as a PDF file and authors will be expected to return their corrections or approval of these proofs within the timeframe given in the email. It is the authors’ responsibility to keep their account in Rapid Review current and to notify the Journal Editorial Office (email@example.com) of any changes in contact information after a paper has been accepted.
In order to provide readers with access to new scientific developments as early as possible, all manuscripts accepted by the editor will be available online prior to being published. Accepted manuscripts are posted as received - without editing or formatting by the publisher. The layout and appearance of each article will change when published in SLEEP.
All papers appearing in SLEEP, including online Accepted Papers, are copyrighted by the Associated Professional Sleep Societies, LLC. No paper in whole or in part may be used in any form without written permission from the Associated Professional Sleep Societies, LLC.
AHEAD OF PRINT
All accepted papers are listed in PubMed as “Ahead of Print (AOP).” This listing includes the abstract of the paper that has been accepted for publication and places it on the PubMed website in advance of final publication. The listing information is created using the copyedited and author approved manuscript of the papers. The abstract from the final, published version of papers will be used to replace the AOP listing on PubMed.
The Ahead of Print initiative was begun to answer the many requests from authors to have the abstract of their papers available shortly after acceptance. The process was started in September 2014. Please note that papers listed as AOP are not to be considered published. All embargo restrictions remain in effect until the final publication date.